Cathepsin K inhibitor 3 structure
|
Common Name | Cathepsin K inhibitor 3 | ||
---|---|---|---|---|
CAS Number | 1694638-70-4 | Molecular Weight | 562.65 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C30H31FN4O4S | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of Cathepsin K inhibitor 3Cathepsin K inhibitor 3 (compound 23) is a highly selective cathepsin K inhibitor with an IC50 value of 0.5 nM. Cathepsin K inhibitor 3 has a favorable pharmacokinetic profile and may be used in osteoarthritis (OA) disease studies[1]. |
Name | Cathepsin K inhibitor 3 |
---|
Description | Cathepsin K inhibitor 3 (compound 23) is a highly selective cathepsin K inhibitor with an IC50 value of 0.5 nM. Cathepsin K inhibitor 3 has a favorable pharmacokinetic profile and may be used in osteoarthritis (OA) disease studies[1]. |
---|---|
Related Catalog | |
Target |
cathepsin K:0.5 nM (IC50) |
In Vivo | Cathepsin K inhibitor 3 (compound 23) (p.o., 0.03-15 mg/kg, daily, 4 days) results in a significant and dose-dependent reduction in uCTX-I, with an 81% reduction in uCTX-1 levels at 0.3 mg/kg and a slightly more complete reduction at 15 mg/kg in dog[1]. The pharmacokinetic parameters of compound 23 Parameters Cl(mL/min/kg) T1/2(h) %F Rat 13 1 33 Dog 3.1 4.1 38 Rhesus 18.5 2.3 55 |
Molecular Formula | C30H31FN4O4S |
---|---|
Molecular Weight | 562.65 |